ArticleScientific reports2025
A lightweight multiscale attention network for 3D tumor segmentation in PET images.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Accurate segmentation of tumor PET images has a significance in disease monitoring and clinical treatment. However, the task of accurately segmenting PET images remains challenging due to insufficient access to spatial features of PET images. Therefore, we propose a multiscale attention-guided feature mechanism for 3D tumor segmentation (MA3DSeg) to achieve accurate segmentation of tumor PET images. Specifically, we first utilize a 3D-DX block to construct a lightweight encoder to minimise the redundant information generated across channel features and reduce the model complexity. Additionally, we employ multiscale attention-guided feature enhancement (MAFE) module for 3D networks to fuse channel features and spatial features to fully acquire spatial feature analysis of tumors. Furthermore, we propose explicit and implicit difference information in interaction boundary semantic (IBS) module to enhance the representation of segmentation edges. We conduct rigorous experiments on three publicly available datasets ECPC-IDS, Hecktor 2022 and AutoPET, which demonstrated superior performance than other competitive networks. MA3DSeg significantly improves Dice by 0.5% on Hecktor 2022 and RVD by 2.1% on ECPC-IDS compared with 3D UX-Net. The experimental results show that MA3DSeg achieves excellent tumor segmentation performance and generalization ability.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.